News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
205,445 Results
Type
Article (9091)
Company Profile (57)
Press Release (196297)
Section
Business (57364)
Career Advice (214)
Deals (10380)
Drug Delivery (34)
Drug Development (25704)
Employer Resources (14)
FDA (6639)
Job Trends (4825)
News (100149)
Policy (8205)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
Academia (808)
Accelerated approval (2)
Adcomms (5)
Allergies (47)
Alliances (20274)
ALS (30)
Alzheimer's disease (428)
Antibody-drug conjugate (ADC) (39)
Approvals (6657)
Artificial intelligence (147)
Autoimmune disease (8)
Automation (13)
Bankruptcy (86)
Best Places to Work (4430)
BIOSECURE Act (1)
Biosimilars (52)
Biotechnology (47)
Bladder cancer (18)
Brain cancer (13)
Breast cancer (108)
Cancer (805)
Cardiovascular disease (75)
Career advice (188)
Career pathing (3)
CAR-T (61)
Cell therapy (191)
Cervical cancer (6)
Clinical research (20734)
Collaboration (456)
Compensation (74)
Complete response letters (8)
COVID-19 (834)
CRISPR (23)
C-suite (59)
Cystic fibrosis (42)
Data (872)
Decentralized trials (1)
Depression (11)
Diabetes (117)
Diagnostics (2850)
Digital health (11)
Diversity, equity & inclusion (4)
Drug discovery (46)
Drug pricing (23)
Drug shortages (13)
Duchenne muscular dystrophy (26)
Earnings (21294)
Editorial (4)
Employer branding (2)
Employer resources (13)
Events (25765)
Executive appointments (216)
FDA (7180)
Featured Employer (16)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (368)
Gene editing (62)
Generative AI (8)
Gene therapy (154)
GLP-1 (360)
Government (1072)
Grass and pollen (2)
Guidances (23)
Healthcare (6266)
Huntington's disease (2)
IgA nephropathy (9)
Immunology and inflammation (47)
Indications (14)
Infectious disease (896)
Inflammatory bowel disease (55)
Inflation Reduction Act (2)
Influenza (26)
Intellectual property (32)
Interviews (31)
IPO (4415)
IRA (6)
Job creations (678)
Job search strategy (163)
Kidney cancer (3)
Labor market (2)
Layoffs (91)
Leadership (1)
Legal (1021)
Liver cancer (21)
Lung cancer (100)
Lymphoma (60)
Machine learning (2)
Management (6)
Manufacturing (160)
MASH (20)
Medical device (5193)
Medtech (5195)
Mergers & acquisitions (6181)
Metabolic disorders (310)
Multiple sclerosis (38)
NASH (2)
Neurodegenerative disease (27)
Neuropsychiatric disorders (3)
Neuroscience (618)
NextGen: Class of 2025 (1895)
Non-profit (1063)
Northern California (924)
Obesity (181)
Opinion (55)
Ovarian cancer (25)
Pain (35)
Pancreatic cancer (23)
Parkinson's disease (59)
Partnered (10)
Patents (62)
Patient recruitment (40)
Peanut (25)
People (12813)
Pharmaceutical (12)
Pharmacy benefit managers (5)
Phase I (6971)
Phase II (8842)
Phase III (6822)
Pipeline (566)
Podcasts (4)
Policy (18)
Postmarket research (812)
Preclinical (2970)
Press Release (32)
Prostate cancer (47)
Psychedelics (6)
Radiopharmaceuticals (146)
Rare diseases (129)
Real estate (1749)
Recruiting (3)
Regulatory (6832)
Reports (19)
Research institute (832)
Resumes & cover letters (25)
Rett syndrome (2)
RNA editing (2)
RSV (14)
Schizophrenia (21)
Series A (71)
Series B (48)
Service/supplier (5)
Sickle cell disease (19)
Southern California (807)
Special edition (2)
Spinal muscular atrophy (46)
Sponsored (18)
Startups (1275)
Stomach cancer (3)
Supply chain (32)
The Weekly (4)
United States (8106)
Vaccines (238)
Venture capitalists (16)
Webinars (2)
Weight loss (120)
Women's health (12)
Worklife (3)
Date
Today (55)
Last 7 days (290)
Last 30 days (1163)
Last 365 days (13512)
2025 (3447)
2024 (13898)
2023 (15478)
2022 (19387)
2021 (19862)
2020 (18932)
2019 (15348)
2018 (11166)
2017 (10784)
2016 (9906)
2015 (11227)
2014 (7765)
2013 (6253)
2012 (6552)
2011 (6758)
2010 (5620)
Location
Africa (156)
Alabama (30)
Alaska (4)
Arizona (57)
Arkansas (10)
Asia (12262)
Australia (2194)
California (2120)
Canada (616)
China (197)
Colorado (105)
Connecticut (114)
Delaware (40)
Europe (30927)
Florida (243)
Georgia (76)
Idaho (22)
Illinois (167)
India (13)
Indiana (129)
Iowa (5)
Japan (53)
Kansas (29)
Kentucky (3)
Louisiana (2)
Maine (15)
Maryland (306)
Massachusetts (1683)
Michigan (63)
Minnesota (116)
Mississippi (2)
Missouri (23)
Montana (4)
Nebraska (9)
Nevada (12)
New Hampshire (38)
New Jersey (700)
New Mexico (15)
New York (595)
North Carolina (378)
North Dakota (7)
Northern California (924)
Ohio (89)
Oklahoma (6)
Oregon (10)
Pennsylvania (388)
Puerto Rico (3)
Rhode Island (7)
South America (221)
South Carolina (8)
South Dakota (1)
Southern California (807)
Tennessee (53)
Texas (309)
Utah (84)
Virginia (45)
Washington D.C. (8)
Washington State (205)
West Virginia (1)
Wisconsin (25)
205,445 Results for "enable injections".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Enable Injections Expands Strategic Partnership with Roche
Enable Injections, Inc. announced the Company has expanded its partnership with Roche through a collaboration, allowing Roche to develop and apply Enable’s expertise and enFuse delivery technology to specific Roche development programs.
May 7, 2024
·
2 min read
Manufacturing
GLP-1 Injectables Will Soon Be Joined by Orals. Is the Industry Ready to Scale?
With crucial lessons learned from the manufacturing shortages of injectable GLP-1s, experts say securing adequate supply of the upcoming oral options will be the sector’s next great challenge.
March 26, 2025
·
6 min read
·
Ben Hargreaves
Patents
Merck’s Injectable Keytruda Plans Create Legal Dispute With Halozyme:
WSJ
The new formulation of Keytruda, currently under FDA review, is sparking conflict with Halozyme, which makes enzymes that convert intravenous drugs into injectable versions.
March 5, 2025
·
1 min read
·
Dan Samorodnitsky
BioMidwest
Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson’s Disease
Enable Injections, Inc. and Serina Therapeutics announced a partnership to develop and commercialize SER-252 in combination with enFuse for the treatment of Parkinson’s disease.
May 15, 2024
·
6 min read
Business
Enable Injections Enhances Board with Addition of Vickie Capps
Enable Injections, Inc., a company developing and manufacturing the enFuse® platform of wearable drug delivery systems, is pleased to announce the appointment of Vickie Capps to the company’s Board of Directors as the head of the audit committee.
November 7, 2023
·
2 min read
Press Releases
Enable Injections Announces Agreement with Sobi® to Develop and Distribute Aspaveli® in Combination with enFuse® in Sobi Territories
September 13, 2024
·
3 min read
FDA
2024 Ends With Greenlights for Merck’s PAH Drug in UK and BMS’ Opdivo Injection in US
Regulators squeezed in two final approvals before the calendar change with the UK approval of Merck’s Winrevair and the FDA’s greenlight for an injectable formulation of BMS’s cancer blockbuster.
January 2, 2025
·
2 min read
·
Kate Goodwin
FDA
Enable Injections Receives First U.S. Food and Drug Administration (FDA) Approval
Enable Injections, Inc. (“Enable”) today announced that the U.S. Food and Drug Administration (FDA) has approved the EMPAVELI Injector (enFuse®) for the subcutaneous delivery of EMPAVELI® (pegcetacoplan), which is commercialized in the United States by Apellis Pharmaceuticals, Inc. for adults with paroxysmal nocturnal hemoglobinuria (PNH).
October 2, 2023
·
2 min read
Cancer
Merck’s Injectable Keytruda Matches IV Formula in Pivotal Trial
Merck’s new formulation of the mega-blockbuster Keytruda, made in collaboration with Alteogen, could help to keep the drug’s patent cliff at bay.
March 28, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
American Injectables Earns FDA Approval
January 9, 2025
·
2 min read
1 of 20,545
Next